Similar articles

• Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.

  Molitch ME, Goodman RH, Post KD, Biller BJ, Moses AC, King LW, Feldman ZT, Reichlin S. Molitch ME, et al. J Clin Endocrinol Metab. 1982 Dec;55(6):1118-23. doi: 10.1210/jcem-55-6-1118. J Clin Endocrinol Metab. 1982. PMID: 7130339
• Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.

  Crosignani PG, Ferrari C, Malinverni A, Barbieri C, Mattei AM, Caldara R, Rocchetti M. Crosignani PG, et al. J Clin Endocrinol Metab. 1980 Nov;51(5):1068-73. doi: 10.1210/jcem-51-5-1068. J Clin Endocrinol Metab. 1980. PMID: 7419682 No abstract available.
• Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.

  Gonzalez-Villapando C, Szabo M, Frohman LA. Gonzalez-Villapando C, et al. J Clin Endocrinol Metab. 1980 Dec;51(6):1417-24. doi: 10.1210/jcem-51-6-1417. J Clin Endocrinol Metab. 1980. PMID: 7440704 No abstract available.
• Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

  Müller EE, Locatelli V, Cella S, Peñalva A, Novelli A, Cocchi D. Müller EE, et al. Drugs. 1983 Apr;25(4):399-432. doi: 10.2165/00003495-198325040-00004. Drugs. 1983. PMID: 6133737 Review.
• [Differential diagnosis of hyperprolactinemia].

  Takeda R, Minagawa F, Nakabayashi H. Takeda R, et al. Nihon Rinsho. 1986 Mar;44(3):671-7. Nihon Rinsho. 1986. PMID: 2874247 Review. Japanese. No abstract available.